Clinical trials
Mycobacterium Abscessus Infection clinical trials
Below are recruiting mycobacterium abscessus infection clinical trials, each written for real people, not researchers. We’re tracking 9 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07301320RecruitingPhase 2
Epetraborole for Mycobacterium abscessus lung infection
This study tests an investigational medication called epetraborole for people with a chronic lung infection caused by Mycobacterium abscessus bacteria. You may be able to join if your infection is stable enough to delay standard treatment and you have symptoms like cough, fatigue, or weight loss.
Portland, OregonAges 18 years+ - NCT07615309Enrolling by invitation
Omadacycline for Mycobacterium abscessus lung infection
This trial tests whether omadacycline (an antibiotic) can safely and effectively treat a rare lung infection caused by Mycobacterium abscessus bacteria. If you have this infection, this study may help doctors understand if this antibiotic works better than current treatments.
BeijingAges 18 years+ - NCT07372781Enrolling by invitationPhase 2
Contezolid for mycobacterium abscessus lung infection
This study tests whether a new antibiotic, Contezolid, can quickly reduce the amount of Mycobacterium abscessus in your lungs. It may be a treatment option if you have had a positive sputum test in the past 6 months.
Beijing, Beijing MunicipalityAges 18–65 - NCT07228702Enrolling by invitationPhase 1
Bacteriophage therapy for one patient with lung infection
This is a special program for one patient with a lung infection from Mycobacterium abscessus. The trial uses a treatment with bacteriophages, which are viruses that attack specific bacteria.
Vancouver, British ColumbiaAges Any age - NCT07295938RecruitingPhase 2
Traditional Chinese medicine as an add-on treatment for mycobacterium abscessus in the lungs
This study tests if adding traditional Chinese medicine to standard treatment helps people with a lung infection called Mycobacterium abscessus. It may improve recovery and reduce side effects.
BeijingAges 18–75 - NCT07369414Recruiting
NTM Germs in CF Homes: A Household Study
This study looks at whether people with cystic fibrosis (CF) can pick up nontuberculous mycobacteria (NTM) from their home environment. It compares homes of people with CF who have NTM to those who don't, to see where germs might be hiding.
Borstel, Schleswig-HolsteinAges Any age - NCT07514364RecruitingPhase 4
Rifabutin for Mycobacterium abscessus lung infection
This study tests whether an antibiotic called rifabutin works better for treating a difficult lung infection (Mycobacterium abscessus) that resists a common antibiotic. You may qualify if you've been diagnosed with this infection and your lab tests show it can resist clarithromycin.
TaipeiAges 18 years+ - NCT04294043RecruitingPhase 1
Gallium IV study for adults with cystic fibrosis and NTM lung infection
This Phase 1 study tests whether an IV medicine called gallium can treat hard-to-treat lung infections (NTM) in adults with cystic fibrosis. It is mainly for people who have not been treated yet for NTM or who have NTM that has not cleared despite antibiotics.
Birmingham, AlabamaAges 18 years+ - NCT04310930RecruitingPhase 2/Phase 3
Find the best treatment plan for a lung infection
This study looks for the best way to treat Mycobacterium abscessus (MABS), a difficult lung infection. You may join a treatment group, or first join an observation group and possibly move into treatment later if you meet the criteria.
Kogarah, New South WalesAges Any age
Hear when a new Mycobacterium Abscessus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mycobacterium abscessus infection?
- Yes. Clin2 currently lists 9 recruiting mycobacterium abscessus infection studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mycobacterium abscessus infection trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mycobacterium abscessus infection trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.